NEW YORK (AP) — Drugs that treat Type 2 diabetes, HIV and arthritis are among 15 new medications chosen for a Medicare drug ...

The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay ...

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.

The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...

Tuesday's announcement is part of the Trump administration's efforts to reduce prescription drug costs for Americans, with ...

The 15 drugs accounted for $27bn in spending via Medicare Part B and Part D between November 2024 and October 2025.

About 1.8 million people used one or more of the 15 drugs through Medicare Part D or Part B between November 2024 and October 2025, the CMS said. The batch of 15 meds accounted for about $27 billion ...

All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their ...

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...